Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 9;22(1):633.
doi: 10.1186/s12884-022-04966-8.

Whole genome non-invasive prenatal testing in prenatal screening algorithm: clinical experience from 12,700 pregnancies

Elena E Baranova  1   2 , Olesya V Sagaydak  1 , Alexandra M Galaktionova  1 , Ekaterina S Kuznetsova  3 , Madina T Kaplanova  1 , Maria V Makarova  1 , Maxim S Belenikin  1 , Anton S Olenev  4 , Ekaterina N Songolova  5
Affiliations

Whole genome non-invasive prenatal testing in prenatal screening algorithm: clinical experience from 12,700 pregnancies

Elena E Baranova et al. BMC Pregnancy Childbirth. .

Abstract

Background: A fast adoption of a non-invasive prenatal testing (NIPT) in clinical practice is a global tendency last years. Firstly, in Russia according a new regulation it was possible to perform a widescale testing of pregnant women in chromosomal abnormality risk. The aim of the study-to assess efficiency of using NIPT as a second-line first trimester screening test in Moscow.

Methods: Based on the first trimester combined prenatal screening results 12,700 pregnant women were classified as a high-risk (cut-off ≥ 1:100) and an intermediate-risk (cut-off 1:101 - 1:2500) groups followed by whole genome NIPT. Women from high-risk group and those who had positive NIPT results from intermediate-risk group were considered for invasive prenatal diagnostic.

Results: 258 (2.0%) samples with positive NIPT results were detected including 126 cases of trisomy 21 (T21), 40 cases of T18, 12 cases of T13, 41 cases of sex chromosome aneuploidies (SCAs) and 39 cases of rare autosomal aneuploidies (RAAs) and significant copy number variations (CNVs). Statistically significant associations (p < 0.05) were revealed for fetal fraction (FF) and both for some patient's (body mass index and weight) and fetus's (sex and high risk of aneuploidies) characteristics. NIPT showed as a high sensitivity as specificity for common trisomies and SCAs with an overall false positive rate 0.3%.

Conclusions: NIPT demonstrated high sensitivity and specificity. As a second-line screening test it has shown a high efficiency in detecting fetus chromosomal anomalies as well as it could potentially lower the number of invasive procedures in pregnant women.

Keywords: Amniocentesis; Fetal aneuploidy; NIPT; Non-invasive prenatal testing; Prenatal screening; Rare autosomal trisomies; Trisomy 13; Trisomy 18; Trisomy 21; cfDNA.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Recruitment criteria for samples that were able to undergo NIPT. *Low-risk group samples were not included into the study. **IPD is obligatory for a high-risk group of pregnant women and is optional for an intermediate-risk group. Abbreviations: NIPT, non–invasive prenatal testing; IPD, invasive prenatal diagnostic
Fig. 2
Fig. 2
Flowchart of non-invasive prenatal test (NIPT) results and invasive prenatal diagnostics outcomes of pregnant women undergoing screening for aneuploidies between 1 April 2020 and 5 April 2021. Abbreviations: T, trisomy; SCA, sex chromosomal aneuploidy; RAA, rare autosomal aneuploidy; CNV, copy number variation; aCGH, array comparative genomic hybridization
Fig. 3
Fig. 3
A density distribution of fetal fraction and its relationship with gestational weeks of pregnant women. The average fetal fraction in each week is shown by a black line
Fig. 4
Fig. 4
The average level of fetal fraction for patients depending on the BMI (a), fetus sex (b) and NIPT results: risk of T21 (c) and T18 (d). Abbreviations: NIPT, non-invasive prenatal testing; T, trisomy; BMI, body mass index.
See this image and copyright information in PMC

References

    1. MacDorman MF. Race and ethnic disparities in fetal mortality, preterm birth, and infant mortality in the United States: an overview. Semin Perinatol. 2011;35(4):200–208. doi: 10.1053/j.semperi.2011.02.017. - DOI - PubMed
    1. Baranov AA, Namazova-Baranova LS, Belyaeva IA, Bombardirova EP, Smirnov IE. Medical and social problems of assisted reproductive technologies from the perspective of pediatrics. Vestn Ross Akad Med Nauk. 2015;3:307–314. doi: 10.15690/vramn.v70i3.1326. - DOI - PubMed
    1. Baranov AA, Namazova-Baranova LS, Albitskiy V, Terletskaya RN. Tendencies of infantile and child mortality in the conditions of implementation of the modern strategy of development of health care of the Russian Federation. Vestnic RAMN. 2017;72(5):375–382.
    1. Sukhikh GT, Karetnikova NA, Baranova EE, Shubina ES, Korostin DO, Evdokimov AN, et al. Noninvasive prenatal diagnosis of aneuploidies by high-throughput sequencing (NGS) in a group of high-risk women. Obstet Gynecol (Moscow) 2016;6:129–157.
    1. Gregg AR, Skotko BG, Benkendorf JL, Monaghan KG, Bajaj K, Best RG, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18(10):1056–1065. doi: 10.1038/gim.2016.97. - DOI - PubMed